Literature DB >> 15509424

Factors associated with participation in a campaign of mass treatment against lymphatic filariasis, in Leogane, Haiti.

E Mathieu1, P J Lammie, J Radday, M J Beach, T Streit, J Wendt, D G Addiss.   

Abstract

In October 2000, to interrupt transmission of Wuchereria bancrofti, an intense health-education campaign followed by a mass drug administration (MDA) with diethylcarbamazine and albendazole was undertaken in Leogane, Haiti. Three months after the MDA, which was the first in the study area, a knowledge-attitude-practice (KAP) survey, with a cluster-sample design and probability sampling, was undertaken, to determine the existing knowledge of the local residents, their attitudes toward the MDA, and the possible reasons for non-compliance. Questionnaire-based interviews were used to explore the KAP of 304 subjects (one randomly chosen resident aged > 14 years from each selected household) in 33 communities. Most (93%) of the interviewees were aware of filariasis and 72% knew at least one clinical sign of the disease. Awareness of the MDA was high (91%). The most frequently mentioned sources of information were other people (56%) and radio announcements (33%). More than 80% of the respondents encouraged other people to take the drugs distributed in the MDA and 63% had been treated. The primary reasons given for failing to take the drugs were absenteeism during the distribution (17%), use of contraceptive drugs (12%) and pregnancy (11%). In a multivariate analysis, being male [odds ratio (OR) = 3.3; 95% confidence interval (CI) = 1.5-7.4], knowing that a mosquito transmits the disease (OR = 2.6; CI = 1.2-5.4), and having learned about the MDA through posters and banners (OR = 2.9; CI = 1.2-7.5) were found to be positively associated with taking the drugs. Information from such post-treatment surveys should be useful in developing better health communication for subsequent MDA.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15509424     DOI: 10.1179/000349804X3135

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  21 in total

1.  Possible relationship among socio-economic determinants, knowledge and practices on lymphatic filariasis and implication for disease elimination in India.

Authors:  Perumal Vanamail; Subbaiah Gunasekaran
Journal:  Int J Public Health       Date:  2010-06-15       Impact factor: 3.380

2.  A community-based study of factors associated with continuing transmission of lymphatic filariasis in Leogane, Haiti.

Authors:  Alexis Boyd; Kimberly Y Won; Shannon K McClintock; Catherine V Donovan; Sandra J Laney; Steven A Williams; Nils Pilotte; Thomas G Streit; Madsen V E Beau de Rochars; Patrick J Lammie
Journal:  PLoS Negl Trop Dis       Date:  2010-03-23

3.  Increasing compliance with mass drug administration programs for lymphatic filariasis in India through education and lymphedema management programs.

Authors:  Paul T Cantey; Jonathan Rout; Grace Rao; John Williamson; LeAnne M Fox
Journal:  PLoS Negl Trop Dis       Date:  2010-06-29

4.  Mass treatment with azithromycin for trachoma control: participation clusters in households.

Authors:  Elizabeth N Ssemanda; Beatriz Munoz; Emma M Harding-Esch; Tansy Edwards; Harran Mkocha; Robin L Bailey; Ansumana Sillah; Dianne Stare; David C W Mabey; Sheila K West
Journal:  PLoS Negl Trop Dis       Date:  2010-10-05

5.  Knowledge and practice related to compliance with mass drug administration during the Egyptian national filariasis elimination program.

Authors:  Khaled M Abd Elaziz; Maged El-Setouhy; Mark H Bradley; Reda M R Ramzy; Gary J Weil
Journal:  Am J Trop Med Hyg       Date:  2013-06-10       Impact factor: 2.345

6.  The role of personal opinions and experiences in compliance with mass drug administration for lymphatic filariasis elimination in Kenya.

Authors:  Doris W Njomo; Mary Amuyunzu-Nyamongo; Japheth K Magambo; Sammy M Njenga
Journal:  PLoS One       Date:  2012-11-19       Impact factor: 3.240

7.  Social mobilisation, drug coverage and compliance and adverse reactions in a Mass Drug Administration (MDA) Programme for the Elimination of Lymphatic Filariasis in Sri Lanka.

Authors:  Mirani V Weerasooriya; Channa T Yahathugoda; Darshana Wickramasinghe; Kithsiri N Gunawardena; Rohan A Dharmadasa; Kanchana K Vidanapathirana; Saman H Weerasekara; Wilfred A Samarawickrema
Journal:  Filaria J       Date:  2007-11-15

8.  Factors associated with the acceptance of mass drug administration for the elimination of lymphatic filariasis in Agusan del Sur, Philippines.

Authors:  Maria Lourdes E Amarillo; Vicente Y Belizario; Jewel T Sadiang-Abay; Stephanie Anne M Sison; Ariane Marie S Dayag
Journal:  Parasit Vectors       Date:  2008-05-27       Impact factor: 3.876

9.  Mass drug administration for elimination of lymphatic filariasis: Recent experiences from a district of West Bengal, India.

Authors:  Santanu Ghosh; Amrita Samanta; Seshadri Kole
Journal:  Trop Parasitol       Date:  2013-01

Review 10.  A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis.

Authors:  Alison Krentel; Peter U Fischer; Gary J Weil
Journal:  PLoS Negl Trop Dis       Date:  2013-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.